BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30480256)

  • 1. RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer's and Parkinson's Diseases.
    Bennett JP; Keeney PM
    J Alzheimers Dis Rep; 2018 Jul; 2(1):129-137. PubMed ID: 30480256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer's Disease and Parkinson's Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia.
    Bennett JP; Keeney PM; Brohawn DG
    Front Neurosci; 2019; 13():235. PubMed ID: 30983949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's and Parkinson's brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130).
    Bennett JP; Keeney PM
    Mitochondrion; 2020 Jul; 53():154-157. PubMed ID: 32497722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).
    Mukherjee S
    Heliyon; 2021 Dec; 7(12):e08518. PubMed ID: 34926857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
    Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic and Genetic Associations between Alzheimer's Disease, Parkinson's Disease, and Cancer.
    Forés-Martos J; Boullosa C; Rodrigo-Domínguez D; Sánchez-Valle J; Suay-García B; Climent J; Falcó A; Valencia A; Puig-Butillé JA; Puig S; Tabarés-Seisdedos R
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
    Tripathi R; Kumar P
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains.
    Dobricic V; Schilling M; Farkas I; Gveric DO; Ohlei O; Schulz J; Middleton L; Gentleman SM; Parkkinen L; Bertram L; Lill CM
    Brain Commun; 2022; 4(6):fcac274. PubMed ID: 36382223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic AI Modeling and Pseudo Time Series Profiling of AD and PD Based on Individualized Serum Proteome Data.
    Zhang J; Zhang X; Sh Y; Liu B; Hu Z
    Front Bioinform; 2021; 1():764497. PubMed ID: 36303784
    [No Abstract]   [Full Text] [Related]  

  • 13. Unraveling Targetable Systemic and Cell-Type-Specific Molecular Phenotypes of Alzheimer's and Parkinson's Brains With Digital Cytometry.
    Bordone MC; Barbosa-Morais NL
    Front Neurosci; 2020; 14():607215. PubMed ID: 33362460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
    Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    Sabbir MG; Speth RC; Albensi BC
    J Alzheimers Dis; 2022; 90(2):727-747. PubMed ID: 36155524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of common and rare variants of Alzheimer's disease-causal genes in Parkinson's disease.
    Zeng Q; Pan H; Zhao Y; Wang Y; Xu Q; Tan J; Yan X; Li J; Tang B; Guo J
    Parkinsonism Relat Disord; 2022 Apr; 97():8-14. PubMed ID: 35276586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.